Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

299
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
299
Multiple Allele Traits01:49

Multiple Allele Traits

38.4K
The Concept of Multiple Allelism
38.4K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

607
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
607
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

327
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
327
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

310
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
310
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

379
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
379

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not All Frailty Assessments Are Created Equal: Comparability of Electronic Health Data-Based Frailty Assessments in Assessing Older People in Residential Care.

Biological research for nursing·2024
Same author

A comparison of approximate versus exact techniques for Bayesian parameter inference in nonlinear ordinary differential equation models.

Royal Society open science·2020
Same author

Delimiting a species' geographic range using posterior sampling and computational geometry.

Scientific reports·2019
Same author

Bayesian change-point modeling with segmented ARMA model.

PloS one·2019
Same author

Methods for identifying SNP interactions: a review on variations of Logic Regression, Random Forest and Bayesian logistic regression.

IEEE/ACM transactions on computational biology and bioinformatics·2011

Related Experiment Video

Updated: Mar 4, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Accurate phenotyping: Reconciling approaches through Bayesian model averaging.

Carla Chia-Ming Chen1,2, Jonathan Macgregor Keith3, Kerrie Lee Mengersen2

  • 1Australian Institute of Marine Science, Cape Cleveland QLD, Australia.

Plos One
|April 20, 2017
PubMed
Summary

Bayesian model averaging improves genetic studies by combining multiple phenotype definitions, enhancing the identification of disease-related genetic loci. This approach consolidates phenotype clusters for more robust linkage analyses.

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.1K

Related Experiment Videos

Last Updated: Mar 4, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.1K

Area of Science:

  • Genetics
  • Biostatistics
  • Computational Biology

Background:

  • Genetic research for complex diseases faces challenges due to imprecise phenotype definition using clinical criteria.
  • Existing statistical methods for phenotype definition yield varying results, impacting downstream genetic analyses.
  • A unified approach is needed to reconcile differing phenotype estimations for improved genetic discovery.

Purpose of the Study:

  • To introduce Bayesian model averaging (BMA) as a novel method for phenotype definition in genetic research.
  • To reconcile phenotype clusters derived from multiple statistical models.
  • To enhance the power of genetic linkage analyses by integrating diverse phenotype data.

Main Methods:

  • Applied latent class analysis (LCA) and grade of membership (GOM) to identify phenotype clusters.
  • Utilized Bayesian model averaging (BMA) to combine and reconcile the distinct clusterings from LCA and GOM.
  • Tested the combined approach on simulated genetic and phenotypic data for a complex disorder.

Main Results:

  • Bayesian model averaging successfully integrated phenotype clusters from separate statistical methods.
  • Genetic linkage analyses using the BMA-integrated phenotypes yielded higher LOD scores compared to individual methods.
  • The improved results are attributed to the consolidation of core phenotype clusters.

Conclusions:

  • Bayesian model averaging offers a robust solution for phenotype definition challenges in genetic research.
  • This method enhances the accuracy and power of identifying genetic loci associated with complex diseases.
  • The study demonstrates the first application of BMA for reconciling multiple phenotype models in genetic studies.